St. Vincent's HealthCare seeking volunteers for colon cancer prevention study
St. Vincent’s HealthCare is seeking volunteers for a national study aimed at reducing the risks of colon cancer.
Researches and doctors, including principal investigator William Sumner III, a St. Vincent’s physician, are working with the National Cancer Institute to evaluate the effectiveness of the drug Rosuvastatin (Crestor) in fighting colon cancer.
The National Surgical Adjuvant Breast and Bowel Project study was developed to evaluate Rosuvastatin, which is generally prescribed by doctors to lower cholesterol and protect against heart attacks. New research suggests statins may also protect against some types of cancer, including colorectal cancer.
Colon cancer is the third most common cancer in the United States. While surgery can be successful in removing colon cancer, polyps often return. If left untreated, polyps can lead to colon cancer. The study will try to determine if the drug will reduce the number of colon polyps in patients with a history of colon cancer.
The study will involve patients who have recently been diagnosed with stage one or stage two cancer and who are not already taking statins for high cholesterol
Anyone who qualifies for the study and is interested in participating should contact Sue Kreichelt, a St. Vincent’s cancer research nurse, at (904) 308-8634.